logo
  Join        Login             Stock Quote

Teva (TEVA) Guides 2013 Below Market Expectations

 November 30, 2012 07:29 AM
 


(By Balachander) Teva Pharmaceutical Industries Ltd (NASDAQ: TEVA) issued its financial forecast for year ending December 2013, trailing market expectations.

The Israel-based generic drugs developer expects non-GAAP earnings per share (EPS) in the range of $4.85 to $5.15, on net revenue between $19.5 billion and $20.5 billion.

Wall Street analysts, on average, expect EPS of $5.65 on revenue of $20.82 billion.

2013 sales outlook consists of total U.S. net revenue of $10 billion to $10.6 billion, total European revenue of $5.5 billion to $6.1 billion, and total rest of the world net revenue of $3.7 billion to $4.3 billion, Teva said.

[Related -Invest In Stocks With A Margin Of Safety To Reduce Risk And Enhance Returns]

The company expects non-GAAP gross profit margin between 59 percent and 61 percent for the next year.

Early November, Teva posted a loss for the third quarter due to a provision for loss contingency of $670 million and impairments of $481 million. Its non-GAAP earnings increased and revenue grew 14.5 percent.

For the year 2012, the company expects non-GAAP EPS between $5.32 and $5.38 on net revenue of $20.1 billion and $20.7 billion. Analysts expect EPS of $5.36 on revenue of $20.36 billion.

American depositary receipts (ADR) of TEVA ended at $40.22 on Thursday.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageChart Says This Retailer's Comeback Isn't Finished

One of the surprises, at least on the surface, of the market's recent swoon was the outperformance of read on...

article imageETF Performance Review: Major Asset Classes | 19 Dec 2014

It’s all about real estate investment trusts (REITs) these days when it comes to bullish performance among read on...

article imageOil and Global Stock Markets Rebounding Sharply

So far so good on our expectation of a 4 to 5% pullback and then a resumption of the bull read on...

article imageGrading the FOMC

Love its members or loathe them, you have to admire the gradual impact the policy-making committee has had read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.